tiprankstipranks
Trending News
More News >
Man Sang International Limited (HK:0938)
:0938

Man Sang International (0938) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0938

Man Sang International

(0938)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
,
Neutral 44 (OpenAI - 5.2)
,
Neutral 44 (OpenAI - 5.2)
,
Neutral 44 (OpenAI - 5.2)
,
Neutral 44 (OpenAI - 5.2)
,
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
HK$0.46
▲(64.64% Upside)
Action:ReiteratedDate:03/18/26
The score is primarily weighed down by weak financial health—ongoing losses, negative cash flows, and a highly leveraged balance sheet with negative equity. Technicals provide some support from a recent rebound and positive MACD, but the very overbought RSI and the price still below the 200-day average add caution. Valuation remains challenged due to negative earnings and no dividend yield data.
Positive Factors
Modest revenue growth
A 7.41% revenue gain demonstrates the company can expand top-line activity despite broader challenges. Sustained revenue growth supports scale benefits, underpins customer retention and provides a foundation for margin recovery if cost control continues, relevant over coming quarters.
Improved gross margin
An 18.46% gross margin improvement points to better pricing or cost efficiency in core operations. Durable margin gains reflect operational leverage, increasing the potential to convert incremental revenue into operating profit if revenue trends persist and fixed costs are managed.
Free cash flow ratio > 1
A free cash flow to net income ratio slightly above 1 suggests cash performance is marginally stronger than accounting profits. Even though absolute cash flows are negative, this relative metric indicates better cash discipline and a nearer-term path to cash stabilization if revenue and cost trends hold.
Negative Factors
Negative equity / high leverage
Negative equity and high leverage (debt-to-equity -2.11) create a structural solvency constraint. This reduces access to affordable financing, elevates refinancing and covenant risk, and forces precautionary capital allocation, materially limiting strategic flexibility over months.
Negative operating and free cash flow
Persistent negative operating and free cash flows undermine the company's ability to fund operations and investments internally. Over time this necessitates external financing or asset disposals, increasing interest burden, dilution risk, and limiting the firm's ability to execute long-term plans.
Core unprofitability
Negative net margin and losses at EBIT/EBITDA levels indicate the core business is unprofitable. Structural unprofitability erodes retained earnings, restricts reinvestment capacity, and means sustainable growth requires either durable cost reduction or meaningful revenue mix improvements.

Man Sang International (0938) vs. iShares MSCI Hong Kong ETF (EWH)

Man Sang International Business Overview & Revenue Model

Company DescriptionMan Sang International Limited, an investment holding company, engages in the development, leasing, and sale of properties in the People's Republic of China. The company sells residential apartments; and leases serviced apartments and shopping mall. It also provides property management, as well as renovation and decoration services. In addition, Man Sang International Limited operates hotel in Japan. The company is based in Chai Wan, Hong Kong. Man Sang International Limited is a subsidiary of China DaDi Group Limited.
How the Company Makes Moneynull

Man Sang International Financial Statement Overview

Summary
Financial statements indicate elevated risk: modest revenue growth (7.41%) but continued losses (negative net margin, EBIT/EBITDA), weak cash generation (negative operating and free cash flow), and a highly stressed balance sheet with negative equity and heavy leverage.
Income Statement
35
Negative
The company shows a modest revenue growth rate of 7.41% in the latest year, but profitability remains a significant concern with a negative net profit margin of -4.29% and negative EBIT and EBITDA margins. The gross profit margin improved to 18.46%, indicating some operational efficiency gains, but overall, the income statement reflects ongoing financial challenges.
Balance Sheet
20
Very Negative
The balance sheet is heavily leveraged with a negative equity position, leading to an unfavorable debt-to-equity ratio of -2.11. The return on equity is positive at 39.62%, but this is due to the negative equity, which distorts the metric. The equity ratio is negative, highlighting the company's financial instability and high-risk profile.
Cash Flow
25
Negative
Cash flow metrics are weak, with negative operating and free cash flows. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow is slightly better than net income, but both are negative. The operating cash flow to net income ratio is also negative, reflecting poor cash generation relative to earnings.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue112.36M138.05M137.14M116.66M158.73M124.85M
Gross Profit33.22M25.48M10.44M-8.39M-24.28M63.04M
EBITDA-37.07M-359.34M-75.70M-68.12M-107.98M-58.16M
Net Income-431.29M-592.21M-482.92M-371.74M-521.82M-190.84M
Balance Sheet
Total Assets252.00M2.03B2.82B3.35B3.50B4.60B
Cash, Cash Equivalents and Short-Term Investments14.31M23.42M32.87M31.77M153.79M1.38B
Total Debt743.66M3.16B2.86B2.82B2.92B3.77B
Total Liabilities839.49M3.52B3.21B3.16B3.31B4.13B
Stockholders Equity-586.74M-1.49B-396.33M191.27M186.42M470.48M
Cash Flow
Free Cash Flow7.67M-6.02M-6.27M-97.40M-101.75M-164.32M
Operating Cash Flow7.94M-5.85M-2.64M-93.91M-98.36M-60.69M
Investing Cash Flow-18.96M-4.07M-9.39M-10.19M-54.53M-157.35M
Financing Cash Flow4.95M14.72M17.63M-29.61M-1.09B1.44B

Man Sang International Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.28
Price Trends
50DMA
0.38
Positive
100DMA
0.41
Positive
200DMA
0.53
Negative
Market Momentum
MACD
0.02
Negative
RSI
65.16
Neutral
STOCH
69.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0938, the sentiment is Positive. The current price of 0.28 is below the 20-day moving average (MA) of 0.40, below the 50-day MA of 0.38, and below the 200-day MA of 0.53, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 65.16 is Neutral, neither overbought nor oversold. The STOCH value of 69.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0938.

Man Sang International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
HK$770.00M3.245.28%4.14%-5.08%27.33%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
61
Neutral
HK$332.44M2.512.29%5.32%9.79%
52
Neutral
HK$318.02M-2.67-4.29%1303.01%-45.00%
50
Neutral
HK$550.32M-5.55242.95%19.34%18.13%
44
Neutral
HK$307.42M-5.04-15.59%24.48%
43
Neutral
HK$203.52M7.722.10%0.88%-25.81%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0938
Man Sang International
0.48
0.03
7.95%
HK:9608
Sundy Service Group Co. Ltd
0.05
-0.05
-50.47%
HK:9982
Central China Management Company Limited
0.09
-0.02
-21.82%
HK:0021
Great China Holdings (Hong Kong) Limited
0.08
-0.03
-24.53%
HK:2205
Kangqiao Service Group Limited
1.10
0.36
48.65%
HK:0432
Pacific Century Premium Developments Limited
0.27
0.07
35.00%

Man Sang International Corporate Events

Man Sang International Plans Major Connected Disposal of Subsidiary and Loan
Mar 12, 2026

Man Sang International has entered into a conditional sale and purchase agreement to dispose of the entire issued share capital of a wholly owned target company and to assign an associated shareholder loan to a purchaser wholly owned by its chairman and controlling shareholder, Mr. Hu. The transaction qualifies as a major disposal and a connected transaction under Hong Kong listing rules, meaning the target will cease to be a subsidiary upon completion and the deal will require independent shareholders’ approval at a special general meeting, with Mr. Hu and his associates abstaining from voting and a circular, independent board committee recommendation, and financial adviser opinion to be provided to investors.

The company plans to dispatch a detailed circular by early April 2026, including financial information on the disposal group and a valuation of the Hokkaido property, to allow shareholders to assess the implications of the proposed disposal. Completion remains subject to various conditions that may be fulfilled or waived, and the company has cautioned shareholders and potential investors that the deal may or may not proceed, underscoring ongoing uncertainty over the eventual impact on the group’s asset base and financial consolidation.

The most recent analyst rating on (HK:0938) stock is a Sell with a HK$0.40 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.

Man Sang International Signs Connected Lease for New Lijiang Hotel Premises
Jan 28, 2026

Man Sang International’s subsidiary Lijiang Hotel has entered into a two-year connected lease agreement with Lijiang Doof to rent approximately 7,554 square metres of premises in Lijiang, Yunnan, for hotel use starting 1 February 2026, or a later date subject to obtaining the necessary operating permits. The lease, which will be recognised as right-of-use assets of about RMB 6.97 million under IFRS 16, qualifies as a connected transaction because Lijiang Doof is ultimately controlled by executive director and controlling shareholder Mr. Hu, triggering reporting and announcement obligations under Hong Kong’s Listing Rules but exempting the deal from independent shareholder approval; failure to secure hotel operation permits by 31 March 2026 will lead to automatic termination of the agreement, underscoring regulatory execution risk around the project.

The most recent analyst rating on (HK:0938) stock is a Hold with a HK$0.39 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.

Man Sang International Executive Director Li Zhenyu to Step Down at End-2025
Dec 31, 2025

Man Sang International Limited has announced that executive director Li Zhenyu will resign from the board with effect from 31 December 2025 to focus on other business commitments, with the company stressing there is no disagreement between him and the board and no issues requiring shareholder attention. The board has expressed its gratitude for Li’s contributions during his tenure and confirmed that the remaining board structure, led by chairman Hu Xingrong and supported by one other executive and three independent non-executive directors, remains in place, suggesting continuity in governance despite the leadership change.

The most recent analyst rating on (HK:0938) stock is a Sell with a HK$0.38 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.

Man Sang International Sets Out Board and Committee Structure
Dec 31, 2025

Man Sang International Limited, a Bermuda-incorporated company listed in Hong Kong, has updated the composition of its board and key governance committees. The company announced its current board structure, confirming Hu Xingrong as chairman and executive director alongside executive director Cong Wenlin, and three independent non-executive directors, Pau Yee Ling, Wong Kwan Kit and Zhou Hong. It also detailed the membership of its audit, remuneration and nomination committees, with independent directors chairing the audit and remuneration committees and the board chairman leading the nomination committee, underscoring the firm’s corporate governance framework and delineation of oversight responsibilities for stakeholders.

The most recent analyst rating on (HK:0938) stock is a Sell with a HK$0.38 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 18, 2026